title: Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup.
abstract: OBJECTIVE
  The efficacy of nerve sparing radical cystoprostatectomy for the treatment of bladder cancer has been evaluated. We reviewed our 10-year experience with this technique to ascertain survival and local recurrence rates.
  
  
  METHODS
  The charts of 101 patients treated with nerve sparing cystoprostatectomy between March 1982 and November 1989 were reviewed and updated.
  
  
  RESULTS
  The disease-specific 10-year survival rate for all stages of bladder cancer treated was 69% and the 10-year survival rate free of local recurrence was 94%. Recovery of sexual function following nerve sparing cystectomy correlated with patient age: 62% in men 40 to 49 years old, 47% in men 50 to 59 years old, 43% in men 60 to 69 years old and 20% in men 70 to 79 years old.
  
  
  CONCLUSIONS
  Nerve sparing radical cystoprostatectomy does not compromise cancer control and provides improved postoperative quality of life.
authors.affiliation: James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland, USA.
authors.forename: M P
authors.initials: MP
authors.lastname: Schoenberg
authors.forename: P C
authors.initials: PC
authors.lastname: Walsh
authors.forename: D R
authors.initials: DR
authors.lastname: Breazeale
authors.forename: F F
authors.initials: FF
authors.lastname: Marshall
authors.forename: J L
authors.initials: JL
authors.lastname: Mostwin
authors.forename: C B
authors.initials: CB
authors.lastname: Brendler
mesh_terms: D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D015653:Cystectomy; D005500:Follow-Up Studies; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*; D010410:Penile Erection; D011468:Prostatectomy; D015996:Survival Rate; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*